 | • レポートコード：GIR-107A12390 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、注射可能駆虫薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。注射可能駆虫薬の種類別市場規模（ベンズイミダゾール、ピペラジン、イミダゾチアゾール、スピロインドール、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、獣医薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・注射可能駆虫薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Cipla、Sun Pharmaceutical Industries、Amneal Pharmaceuticals、Zoetis、GlaxoSmithKline、Bayer、Merck、Boehringer Ingelheim International ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ベンズイミダゾール、ピペラジン、イミダゾチアゾール、スピロインドール、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局、獣医薬局、その他 ・注射可能駆虫薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・注射可能駆虫薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・注射可能駆虫薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・注射可能駆虫薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・注射可能駆虫薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Injectable Anthelmintic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Injectable Anthelmintic Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Injectable Anthelmintic Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Injectable Anthelmintic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Benzimidazoles
Piperazine
Imidazothiazole
Spiroindoles
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Veterinary Pharmacies
Others
Market segment by players, this report covers
Novartis
Cipla
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Zoetis
GlaxoSmithKline
Bayer
Merck
Boehringer Ingelheim International
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Injectable Anthelmintic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Injectable Anthelmintic Drugs, with revenue, gross margin and global market share of Injectable Anthelmintic Drugs from 2019 to 2021.
Chapter 3, the Injectable Anthelmintic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Injectable Anthelmintic Drugs market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Injectable Anthelmintic Drugs research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Injectable Anthelmintic Drugs
1.2 Classification of Injectable Anthelmintic Drugs by Type
1.2.1 Overview: Global Injectable Anthelmintic Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Type in 2020
1.2.3 Benzimidazoles
1.2.4 Piperazine
1.2.5 Imidazothiazole
1.2.6 Spiroindoles
1.2.7 Others
1.3 Global Injectable Anthelmintic Drugs Market by Application
1.3.1 Overview: Global Injectable Anthelmintic Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Veterinary Pharmacies
1.3.6 Others
1.4 Global Injectable Anthelmintic Drugs Market Size & Forecast
1.5 Global Injectable Anthelmintic Drugs Market Size and Forecast by Region
1.5.1 Global Injectable Anthelmintic Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Injectable Anthelmintic Drugs Market Size by Region, (2016-2021)
1.5.3 North America Injectable Anthelmintic Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Injectable Anthelmintic Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Injectable Anthelmintic Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Injectable Anthelmintic Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Injectable Anthelmintic Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Injectable Anthelmintic Drugs Market Drivers
1.6.2 Injectable Anthelmintic Drugs Market Restraints
1.6.3 Injectable Anthelmintic Drugs Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Injectable Anthelmintic Drugs Product and Solutions
2.1.4 Novartis Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Cipla
2.2.1 Cipla Details
2.2.2 Cipla Major Business
2.2.3 Cipla Injectable Anthelmintic Drugs Product and Solutions
2.2.4 Cipla Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Cipla Recent Developments and Future Plans
2.3 Sun Pharmaceutical Industries
2.3.1 Sun Pharmaceutical Industries Details
2.3.2 Sun Pharmaceutical Industries Major Business
2.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product and Solutions
2.3.4 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
2.4 Amneal Pharmaceuticals
2.4.1 Amneal Pharmaceuticals Details
2.4.2 Amneal Pharmaceuticals Major Business
2.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product and Solutions
2.4.4 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Amneal Pharmaceuticals Recent Developments and Future Plans
2.5 Zoetis
2.5.1 Zoetis Details
2.5.2 Zoetis Major Business
2.5.3 Zoetis Injectable Anthelmintic Drugs Product and Solutions
2.5.4 Zoetis Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Zoetis Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Product and Solutions
2.6.4 GlaxoSmithKline Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business
2.7.3 Bayer Injectable Anthelmintic Drugs Product and Solutions
2.7.4 Bayer Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Bayer Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Injectable Anthelmintic Drugs Product and Solutions
2.8.4 Merck Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Merck Recent Developments and Future Plans
2.9 Boehringer Ingelheim International
2.9.1 Boehringer Ingelheim International Details
2.9.2 Boehringer Ingelheim International Major Business
2.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Product and Solutions
2.9.4 Boehringer Ingelheim International Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Boehringer Ingelheim International Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Injectable Anthelmintic Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Injectable Anthelmintic Drugs Players Market Share
3.2.2 Top 10 Injectable Anthelmintic Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Injectable Anthelmintic Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Injectable Anthelmintic Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Injectable Anthelmintic Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2016-2021)
5.2 Injectable Anthelmintic Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Injectable Anthelmintic Drugs Revenue by Type (2016-2026)
6.2 North America Injectable Anthelmintic Drugs Revenue by Application (2016-2026)
6.3 North America Injectable Anthelmintic Drugs Market Size by Country
6.3.1 North America Injectable Anthelmintic Drugs Revenue by Country (2016-2026)
6.3.2 United States Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Injectable Anthelmintic Drugs Revenue by Type (2016-2026)
7.2 Europe Injectable Anthelmintic Drugs Revenue by Application (2016-2026)
7.3 Europe Injectable Anthelmintic Drugs Market Size by Country
7.3.1 Europe Injectable Anthelmintic Drugs Revenue by Country (2016-2026)
7.3.2 Germany Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
7.3.3 France Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Injectable Anthelmintic Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Injectable Anthelmintic Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region
8.3.1 Asia-Pacific Injectable Anthelmintic Drugs Revenue by Region (2016-2026)
8.3.2 China Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
8.3.5 India Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Injectable Anthelmintic Drugs Revenue by Type (2016-2026)
9.2 South America Injectable Anthelmintic Drugs Revenue by Application (2016-2026)
9.3 South America Injectable Anthelmintic Drugs Market Size by Country
9.3.1 South America Injectable Anthelmintic Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Injectable Anthelmintic Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Injectable Anthelmintic Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country
10.3.1 Middle East & Africa Injectable Anthelmintic Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Injectable Anthelmintic Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Injectable Anthelmintic Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Injectable Anthelmintic Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Injectable Anthelmintic Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Injectable Anthelmintic Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Injectable Anthelmintic Drugs Revenue Market Share by Region (2021-2026)
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis Injectable Anthelmintic Drugs Product and Solutions
Table 9. Novartis Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Cipla Corporate Information, Head Office, and Major Competitors
Table 11. Cipla Major Business
Table 12. Cipla Injectable Anthelmintic Drugs Product and Solutions
Table 13. Cipla Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sun Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 15. Sun Pharmaceutical Industries Major Business
Table 16. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product and Solutions
Table 17. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Amneal Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Amneal Pharmaceuticals Major Business
Table 20. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product and Solutions
Table 21. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Zoetis Corporate Information, Head Office, and Major Competitors
Table 23. Zoetis Major Business
Table 24. Zoetis Injectable Anthelmintic Drugs Product and Solutions
Table 25. Zoetis Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 27. GlaxoSmithKline Major Business
Table 28. GlaxoSmithKline Injectable Anthelmintic Drugs Product and Solutions
Table 29. GlaxoSmithKline Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Bayer Corporate Information, Head Office, and Major Competitors
Table 31. Bayer Major Business
Table 32. Bayer Injectable Anthelmintic Drugs Product and Solutions
Table 33. Bayer Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Merck Corporate Information, Head Office, and Major Competitors
Table 35. Merck Major Business
Table 36. Merck Injectable Anthelmintic Drugs Product and Solutions
Table 37. Merck Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Boehringer Ingelheim International Corporate Information, Head Office, and Major Competitors
Table 39. Boehringer Ingelheim International Major Business
Table 40. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product and Solutions
Table 41. Boehringer Ingelheim International Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Injectable Anthelmintic Drugs Revenue (USD Million) by Players (2019-2021)
Table 43. Global Injectable Anthelmintic Drugs Revenue Share by Players (2019-2021)
Table 44. Breakdown of Injectable Anthelmintic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Injectable Anthelmintic Drugs Players Head Office, Products and Services Provided
Table 46. Injectable Anthelmintic Drugs Mergers & Acquisitions in the Past Five Years
Table 47. Injectable Anthelmintic Drugs New Entrants and Expansion Plans
Table 48. Global Injectable Anthelmintic Drugs Revenue (USD Million) by Type (2016-2021)
Table 49. Global Injectable Anthelmintic Drugs Revenue Share by Type (2016-2021)
Table 50. Global Injectable Anthelmintic Drugs Revenue Forecast by Type (2021-2026)
Table 51. Global Injectable Anthelmintic Drugs Revenue by Application (2016-2021)
Table 52. Global Injectable Anthelmintic Drugs Revenue Forecast by Application (2021-2026)
Table 53. North America Injectable Anthelmintic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Injectable Anthelmintic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Injectable Anthelmintic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Injectable Anthelmintic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Injectable Anthelmintic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Injectable Anthelmintic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Injectable Anthelmintic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Injectable Anthelmintic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Injectable Anthelmintic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Injectable Anthelmintic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Injectable Anthelmintic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Injectable Anthelmintic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Injectable Anthelmintic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Injectable Anthelmintic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Injectable Anthelmintic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Injectable Anthelmintic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Injectable Anthelmintic Drugs Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Injectable Anthelmintic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Injectable Anthelmintic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Injectable Anthelmintic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Injectable Anthelmintic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Injectable Anthelmintic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Injectable Anthelmintic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Injectable Anthelmintic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Injectable Anthelmintic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Injectable Anthelmintic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Injectable Anthelmintic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Injectable Anthelmintic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Injectable Anthelmintic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Injectable Anthelmintic Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Injectable Anthelmintic Drugs Picture
Figure 2. Global Injectable Anthelmintic Drugs Revenue Market Share by Type in 2020
Figure 3. Benzimidazoles
Figure 4. Piperazine
Figure 5. Imidazothiazole
Figure 6. Spiroindoles
Figure 7. Others
Figure 8. Injectable Anthelmintic Drugs Revenue Market Share by Application in 2020
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Veterinary Pharmacies Picture
Figure 13. Others Picture
Figure 14. Global Injectable Anthelmintic Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Injectable Anthelmintic Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Injectable Anthelmintic Drugs Revenue Market Share by Region (2016-2026)
Figure 17. Global Injectable Anthelmintic Drugs Revenue Market Share by Region in 2020
Figure 18. North America Injectable Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Injectable Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Injectable Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Injectable Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Injectable Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Injectable Anthelmintic Drugs Market Drivers
Figure 24. Injectable Anthelmintic Drugs Market Restraints
Figure 25. Injectable Anthelmintic Drugs Market Trends
Figure 26. Novartis Recent Developments and Future Plans
Figure 27. Cipla Recent Developments and Future Plans
Figure 28. Sun Pharmaceutical Industries Recent Developments and Future Plans
Figure 29. Amneal Pharmaceuticals Recent Developments and Future Plans
Figure 30. Zoetis Recent Developments and Future Plans
Figure 31. GlaxoSmithKline Recent Developments and Future Plans
Figure 32. Bayer Recent Developments and Future Plans
Figure 33. Merck Recent Developments and Future Plans
Figure 34. Boehringer Ingelheim International Recent Developments and Future Plans
Figure 35. Global Injectable Anthelmintic Drugs Revenue Share by Players in 2020
Figure 36. Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Injectable Anthelmintic Drugs Revenue Market Share in 2020
Figure 38. Global Top 10 Players Injectable Anthelmintic Drugs Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Injectable Anthelmintic Drugs Revenue Share by Type in 2020
Figure 41. Global Injectable Anthelmintic Drugs Market Share Forecast by Type (2021-2026)
Figure 42. Global Injectable Anthelmintic Drugs Revenue Share by Application in 2020
Figure 43. Global Injectable Anthelmintic Drugs Market Share Forecast by Application (2021-2026)
Figure 44. North America Injectable Anthelmintic Drugs Sales Market Share by Type (2016-2026)
Figure 45. North America Injectable Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 46. North America Injectable Anthelmintic Drugs Revenue Market Share by Country (2016-2026)
Figure 47. United States Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Injectable Anthelmintic Drugs Sales Market Share by Type (2016-2026)
Figure 51. Europe Injectable Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 52. Europe Injectable Anthelmintic Drugs Revenue Market Share by Country (2016-2026)
Figure 53. Germany Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Injectable Anthelmintic Drugs Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Injectable Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Injectable Anthelmintic Drugs Revenue Market Share by Region (2016-2026)
Figure 61. China Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Injectable Anthelmintic Drugs Sales Market Share by Type (2016-2026)
Figure 68. South America Injectable Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 69. South America Injectable Anthelmintic Drugs Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Injectable Anthelmintic Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Injectable Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Injectable Anthelmintic Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Injectable Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の凍結乾燥注射薬市場予測（～2024年） Scope of the Report: Based on type of packaging, the single-use vials segment is anticipated held major market share in 2018 and the trend is projected to continue during the forecast period. The global Lyophilized Injectable Drugs market is valued at xx million USD in 2018 and is expected to reach …- 世界の腫瘍ジェネリック注射薬市場 2021：企業別、地域別、種類・用途別 The Oncology Generic Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の腫瘍ジェネリック注射薬市場予測（～2024年） Generic drugs are essential in oncology because some anticancer drugs are only available as generics. Scope of the Report: The worldwide market for Oncology Generic Injectable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx mill…
- 世界の注射可能神経修飾物質市場 2021：企業別、地域別、種類・用途別 The Neuromodulators Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界のポルフィリン症薬市場予測（～2024年） Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system. Scope of the Report: The worldwide market for Porphyrias Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, f…